EU OKs Novartis-Alcon Deal Following Sale Of Assets
The European Commission has approved Novartis AG's bid to take over a majority stake in Alcon Laboratories Inc. based on Novartis' promise to sell off several ophthalmological drugs and consumer eye...To view the full article, register now.
Already a subscriber? Click here to view full article